Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-22 Sale |
2021-09-23 5:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $30.82 | $123,280 | 221,077 (Direct) |
View |
| 2021-09-15 Sale |
2021-09-17 5:20 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $33.64 | $134,579 | 1,550,927 (Indirect Direct) |
View |
| 2021-09-07 Sale |
2021-09-08 5:31 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $32.03 | $128,120 | 225,077 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 5:30 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
50,000 | $33.18 | $1,658,915 | 1,773,927 (Indirect Direct) |
View |
| 2021-08-23 Sale |
2021-08-24 5:02 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $28.6 | $114,400 | 229,077 (Direct) |
View |
| 2021-08-13 Sale |
2021-08-17 6:32 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
29,000 | $29.35 | $851,023 | 1,554,927 (Indirect) |
View |
| 2021-08-12 Purchase |
2021-08-13 5:41 pm |
Y-mAbs Therapeutics Inc. | YMAB | Rajah Vignesh SVP & CMO |
1,374 | $29.95 | $41,147 | 3,071 (Indirect) |
View |
| 2021-08-04 Sale |
2021-08-05 5:20 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $33.72 | $134,880 | 233,077 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-05 5:18 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $33.73 | $134,927 | 1,583,927 (Indirect) |
View |
| 2021-07-22 Sale |
2021-07-26 06:19 am |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $34.5 | $138,000 | 237,077 (Direct) |
View |
| 2021-07-20 Sale |
2021-07-21 6:56 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $32.47 | $129,875 | 1,587,927 (Indirect) |
View |
| 2021-07-07 Sale |
2021-07-08 5:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $31.87 | $127,465 | 1,591,927 (Indirect) |
View |
| 2021-07-06 Sale |
2021-07-07 6:00 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $34.15 | $136,600 | 241,077 (Direct) |
View |
| 2021-06-30 Sale |
2021-07-02 4:31 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $33.86 | $135,446 | 1,595,927 (Indirect) |
View |
| 2021-06-22 Sale |
2021-06-23 4:30 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $36.17 | $144,680 | 245,077 (Direct) |
View |
| 2021-06-14 Sale |
2021-06-15 5:06 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $35.8 | $143,217 | 1,599,927 (Indirect) |
View |
| 2021-06-10 Sale |
2021-06-11 5:01 pm |
Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS See remarks |
11,229 | $36.15 | $405,971 | 4,178,456 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-11 5:00 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
11,229 | $36.15 | $405,971 | 4,178,465 (Indirect) |
View |
| 2021-06-08 Sale |
2021-06-10 7:00 pm |
Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS See Remarks |
150,000 | $35.99 | $5,397,810 | 4,189,694 (Direct) |
View |
| 2021-06-08 Sale |
2021-06-10 6:35 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
150,000 | $35.99 | $5,397,810 | 4,189,694 (Indirect) |
View |
| 2021-06-07 Sale |
2021-06-09 6:51 pm |
Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS 10% Owner |
72,400 | $34.15 | $2,472,583 | 4,339,694 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-09 6:49 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
72,400 | $34.15 | $2,472,583 | 4,339,694 (Indirect) |
View |
| 2021-06-03 Sale |
2021-06-07 4:31 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
34,507 | $33.28 | $1,148,373 | 4,412,094 (Indirect) |
View |
| 2021-06-03 Sale |
2021-06-07 4:30 pm |
Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS 10% Owner |
34,507 | $33.28 | $1,148,373 | 4,412,094 (Direct) |
View |
| 2021-06-04 Sale |
2021-06-07 4:30 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $33.48 | $133,920 | 249,077 (Direct) |
View |
| 2021-05-28 Sale |
2021-06-02 4:32 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
31,864 | $36.17 | $1,152,648 | 4,446,601 (Indirect) |
View |
| 2021-05-28 Sale |
2021-06-02 4:31 pm |
Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS 10% Owner |
31,864 | $36.17 | $1,152,648 | 4,446,601 (Direct) |
View |
| 2021-05-28 Sale |
2021-06-01 4:32 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $36.95 | $147,813 | 1,603,927 (Indirect) |
View |
| 2021-05-24 Sale |
2021-05-26 4:33 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $35.61 | $142,440 | 253,077 (Direct) |
View |
| 2021-05-18 Sale |
2021-05-20 4:32 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $34.07 | $136,290 | 1,607,927 (Indirect) |
View |
| 2021-04-26 Sale |
2021-04-28 4:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $27.96 | $195,731 | 1,880,927 (Indirect Direct) |
View |
| 2021-04-12 Sale |
2021-04-14 5:00 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
11,000 | $26.6 | $292,641 | 1,887,927 (Indirect Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 4:35 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
15,000 | $30.26 | $453,946 | 1,898,927 (Indirect Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 4:35 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
11,000 | $36.79 | $404,656 | 1,913,927 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-07 Exercise |
2021-09-07 5:30 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
50,000 | $2 | 1,773,927 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-07 5:30 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
50,000 | $0 | 1,773,927 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:06 pm |
2021-07-10 2031-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Hamill Laura Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:05 pm |
2021-07-10 2031-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:04 pm |
2021-07-10 2031-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | HEALY JAMES Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:03 pm |
2021-07-10 2031-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Ber Gerard Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:03 pm |
2021-07-10 2031-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:02 pm |
2021-07-10 2031-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | TYAGI ASHU Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-04-26 Exercise |
2021-04-28 4:16 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $2 | 1,880,927 (Direct) |
View |
| 2021-04-26 Exercise |
2021-04-28 4:16 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $0 | 1,880,927 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-14 5:00 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $2 | 1,887,927 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-14 5:00 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $0 | 1,887,927 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 4:35 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
9,000 | $2 | 1,898,927 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 4:35 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
9,000 | $0 | 1,898,927 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-17 4:35 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $2 | 1,913,927 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-17 4:35 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $0 | 1,913,927 (Direct) |
View |